Qin Qin, Wu Zhengcan, Bao Lianyun, Chen Hui, Yang Liping, He Zifang, Huang Zhenping
Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated to Nanjing University Medical School.
Department of Ophthalmology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University.
Medicine (Baltimore). 2019 Nov;98(44):e17677. doi: 10.1097/MD.0000000000017677.
The purpose of this retrospective study was to evaluate the visual quality, objective scattering index, aberration, etc after Implantable Collamer Lens with center hole (EVO-ICL) implantation to treat patients with hypermyopia (diopter > -10 D).A total of 30 eyes underwent EVO-ICL implantation. The uncorrected distance visual acuity (UDVA), best-corrected visual acuity (BCVA), equivalent spherical degree, aberration, visual quality parameters, and corneal endothelial cell density were compared preoperative and postoperative. Fill in the National Eye Institute Refractive Error Quality of Life Instrument-42 before and after surgery.The modulation transfer function (MTF), Optical Quality Analysis System (OQAS) II values (OV 100%, 20%, 9%), and Stahl ratio 1 and 3 months after surgery were higher than the respective preoperative values. The objective scatter index value increased 1 week after surgery, but decreased 1 and 3 months after surgery compared with the preoperative values. Total aberration (TA), total low-order aberration (tLOAs), and defocus decreased at 1 week and 3 months after EVO-ICL implantation. Total high-order aberration (tHOAs) and spherical aberration were significantly increased 1 week after surgery and decreased 3 months after surgery, and the difference was statistically significant. Astigmatism, coma, and clover were not significantly different in each time period. TA, tLOAs, tHOAs, defocus, and spherical aberration were higher at 1 week than 3 months after surgery. At 3 months after surgery, the scores of the patients' NEI-RQL-42 scale were all improved except that the glare was lower than that before surgery. There was no significant difference in the density of corneal endothelial cells before and 3 months after surgery.For patients with hypermyopia, the postoperative subjective and objective visual quality of EVO-ICL implantation was better than preoperative.
这项回顾性研究的目的是评估有中心孔的可植入胶原晶状体(EVO-ICL)植入治疗高度近视患者(屈光度>-10D)后的视觉质量、客观散射指数、像差等。共30只眼接受了EVO-ICL植入。比较术前和术后的未矫正远视力(UDVA)、最佳矫正视力(BCVA)、等效球镜度、像差、视觉质量参数和角膜内皮细胞密度。手术前后填写美国国立眼科研究所屈光不正生活质量量表-42。术后1个月和3个月的调制传递函数(MTF)、光学质量分析系统(OQAS)II值(OV 100%、20%、9%)以及斯塔尔比率均高于各自的术前值。客观散射指数值在术后1周升高,但与术前值相比,在术后1个月和3个月降低。EVO-ICL植入术后1周和3个月,总像差(TA)、总低阶像差(tLOAs)和散焦降低。总高阶像差(tHOAs)和球差在术后1周显著增加,术后3个月降低,差异有统计学意义。散光、彗差和三叶像差在各时间段无显著差异。TA、tLOAs、tHOAs、散焦和球差在术后1周高于术后3个月。术后3个月,除眩光低于术前外,患者的NEI-RQL-42量表评分均有所改善。手术前和术后3个月角膜内皮细胞密度无显著差异。对于高度近视患者,EVO-ICL植入术后主观和客观视觉质量均优于术前。